StockVS

Soren Acquisition Corp. (SORN) 股票分析

金融服务

Soren Acquisition Corp.

$9.92

+$0.00 (+0.00%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

Soren Acquisition Corp. is a special purpose acquisition company (SPAC) that focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company specifically intends to target businesses within the healthcare industry, positioning itself as a vehicle for capitalizing on opportunities in that specific sector. It operates within the Financial Services sector and the Shell Companies industry, classifications that define its role as a temporary vehicle awaiting a business combination rather than a traditional operating entity. The company's scale is characterized by a market capitalization of $343.86M, while its annual revenue and employee count are listed as N/A in available data. These valuation figures indicate that the company holds a significant market presence relative to typical shell companies, suggesting a substantial capital base available for a future transaction, even in the absence of traditional operating revenue or headcount metrics.

财务健康

The financial health of Soren Acquisition Corp. is defined by a net income (TTM) of $-249,627, while revenue and EBITDA figures are reported as N/A due to its SPAC structure. The gap between nominal revenue and negative net income reveals a cost structure driven entirely by organizational and transaction expenses rather than operational costs associated with selling goods or services. Free cash flow is listed as N/A, indicating that the company does not generate operating cash flow typical of mature businesses and relies on initial public offering proceeds for liquidity. All three margins—Gross Margin, Operating Margin, and Profit Margin—are reported as 0.0%, which indicates that the company has not yet generated taxable income from operations and exists primarily as a holding vehicle. Total cash is listed as N/A, whereas total debt stands at $13,320, creating a debt-to-equity ratio of 153.62. This high debt-to-equity ratio suggests a leveraged balance sheet relative to its equity base, a common characteristic for SPACs prior to a merger, though the specific leverage implications depend on the timing of the business combination. The current ratio is 0.05, which indicates extremely low short-term liquidity relative to short-term obligations, reflecting the fact that assets are largely held in trust rather than as liquid working capital for daily operations. Return on Equity and Return on Assets are both listed as N/A, meaning that these return metrics cannot be calculated in a meaningful way until the company completes a business combination and begins generating returns on invested capital.

估值评估

The trailing P/E ratio and forward P/E ratio are both listed as N/A, reflecting the company's lack of consistent earnings and the speculative nature of valuing a pre-merger SPAC where future earnings trajectories are undefined. The price-to-book ratio is -1237.50, a figure that indicates a market valuation that is detached from book value, a standard metric anomaly for shell companies where assets are primarily cash held in trust rather than tangible operating assets. The price-to-sales ratio and EV/EBITDA are also reported as N/A, suggesting that traditional relative valuation metrics are not applicable until the company transitions from a shell to an operating entity with sales and earnings. The 52-week high is $10.88 and the 52-week low is $9.81, meaning the current trading price sits within this historical range but does not necessarily imply a premium or discount relative to the broader SPAC market without a specific closing price context. The beta value is listed as N/A, which implies that the stock's price volatility relative to the broader market cannot be quantified using standard statistical measures due to limited trading volume or specific SPAC listing characteristics. These valuation metrics collectively suggest that the stock is priced based on the potential of the future target acquisition rather than current fundamental performance indicators.

Growth & Income

Revenue growth and earnings growth rates are both listed as N/A, indicating that the company has not yet achieved sustained growth as an operating business and that earnings are not expanding in the traditional sense. Since the company does not pay dividends, the dividend yield and payout ratio are listed as N/A, which means the company reinvests its available capital into the search for a target business combination rather than distributing cash to shareholders. The overall growth and income profile is currently speculative, with no historical growth rates to analyze and no income generation to support a dividend distribution strategy. This profile aligns with the typical lifecycle of a SPAC, where the focus is entirely on executing a merger to unlock value rather than delivering immediate growth or income returns to investors.

同行比较

Soren Acquisition Corp. (SORN) 在壳公司行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Soren Acquisition Corp. SORN $344.55M N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

壳公司行业平均市盈率为82.8倍。Soren Acquisition Corp.的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Soren Acquisition Corp.

Soren Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company intends to focus on target businesses in the healthcare industry. Soren Acquisition Corp. was incorporated in 2025 and is based in Miami, Florida.

公司简介以英文显示。

关键指标

市值
$344.55M
市盈率
N/A
52周最高
$10.88
52周最低
$9.81
平均成交量
31.40K

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States